Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-11

FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (POLYGEN PHARMACEUTICALS INC.)

View source ↗

Summary

The FDA approved an original ANDA for memantine hydrochloride by PolyGen Pharmaceuticals, enabling a generic version of memantine for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MEMANTINE HYDROCHLORIDE (Memantine hydrochloride)

Snippet

ORIG AP for MEMANTINE HYDROCHLORIDE (MEMANTINE HYDROCHLORIDE)